

Don't waste time calling pharmacies. Learn how to check if Merilog (insulin aspart-szjj) is in stock near you using online tools, apps, and Medfinder.
You've got the prescription. Now you need to actually find Merilog at a pharmacy — and if you've ever tried calling around to check stock on a newer medication, you know it can be a frustrating, time-consuming process. The hold times, the transfers, the "let me check... no, we don't carry that."
There's a better way. Here's how to check if a pharmacy has Merilog (Insulin Aspart-szjj) in stock without picking up the phone.
Merilog was FDA-approved in February 2025 and launched by Sanofi in July 2025. As a relatively new biosimilar insulin, not every pharmacy has added it to their regular inventory yet. Pharmacies typically stock medications based on demand, and it takes time for a new product to build a track record of prescriptions in any given area.
On top of that, the insulin market is in a period of transition. Novo Nordisk discontinued its unbranded Insulin Aspart biologic at the end of 2025, and Fiasp pen shortages have continued into early 2026. This shifting landscape means pharmacies are still adjusting their insulin inventories. For more context, read our guide on why Merilog can be hard to find.
Medfinder is the fastest way to check pharmacy stock for Merilog. Just enter the medication name, your location, and Medfinder shows you which pharmacies near you have it available — along with pricing information. No account needed. No phone calls. It's specifically designed for situations like this, where you need to find a medication that isn't available everywhere.
Many major pharmacy chains let you check medication availability through their apps or websites:
Keep in mind: these tools show whether a pharmacy can fill a prescription, but real-time stock levels aren't always reflected. If the app says a medication is available but you want to be sure, a quick chat through the app may confirm it.
GoodRx isn't just a coupon tool — it also shows which pharmacies near you carry a specific medication and what they charge. Search for "Merilog" or "Insulin Aspart-szjj" on GoodRx, enter your zip code, and you'll see a list of pharmacies with prices. If a pharmacy shows a price, it generally means they carry or can order the medication.
If you have insurance, your plan's website or app may have a pharmacy finder that shows which in-network pharmacies have specific medications available. This is especially useful for confirming that a pharmacy both has Merilog in stock and accepts your insurance.
If local availability is an issue, consider a mail-order pharmacy. Many insurance plans offer mail-order options (like Express Scripts, CVS Caremark, or OptumRx) that ship medications directly to your home. Mail-order pharmacies often have better access to newer medications since they operate from centralized distribution centers. The downside: it may take a few days to arrive, so plan ahead.
Sometimes a quick phone call is the most direct route. If you want to call pharmacies to check stock, here are some tips to save time:
After you've located a pharmacy with Merilog in stock, here are a few things to do:
Finding Merilog shouldn't require an afternoon of phone calls. Tools like Medfinder make it easy to check stock at pharmacies near you in seconds. As Merilog becomes more established in 2026, availability should improve — but in the meantime, using the right tools saves you time and frustration.
If you're having trouble finding Merilog at all, our guide on how to find Merilog in stock near you covers even more strategies, including working with your doctor on alternative options if needed.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.